Core Scientific Creations Ltd

Core Scientific Creations Ltd manufactures WoundClot Advanced, a next-generation hemostatic gauze for bleeding control across surgical, emergency, and perioperative settings. The product is engineered from non-oxidized, non-regenerated cellulose (NONRCS) that converts to a thick, tenacious 3D gel matrix upon contact with blood. WoundClot offers rapid hemostasis through four mechanisms: absorption (up to 2,500% of weight in blood, active for 24 hours), aggregation of platelets and clotting factors, adhesion to wound tissue without dislodgement during movement or high-pressure bleeding, and activation of clotting factors (PTA XI and Hageman XII). Unlike kaolin and silica-based alternatives, WoundClot does not cause rebleeding when removed, does not leach particles, and requires no compression or packing for efficacy. The company markets to hospitals, EMS/first responders, law enforcement, and military. Product lines include WoundClot Hospital (surgical and perioperative use) and WoundClot EMS/First Responder formulations. Clinical applications span trauma surgery, plastic surgery, orthopedic procedures (hips, knees, shoulders), foot/ankle surgery, emergency departments, hand/extremity surgery, pacemaker pocket bleeding, wound care, dermatology, and burn management. The gauze is biodegradable, value-priced, easy to apply with minimal training, safe for first responders, stable across temperature ranges (-10°C to 40°C), and effective in austere conditions. The company emphasizes that its team comprises subject matter experts with over a century of combined healthcare experience.